Vitrolife AB (OSTO:VITR) Institutional Ownership : 29.16% (As of May. 18, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vitrolife AB's institutional ownership is 29.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vitrolife AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vitrolife AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Vitrolife AB Institutional Ownership Historical Data

The historical data trend for Vitrolife AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Institutional Ownership Chart

Vitrolife AB Historical Data

The historical data trend for Vitrolife AB can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	29.63	29.28	29.42	28.45	29.10	29.83	29.81	28.98	28.98	29.16

Vitrolife AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Vitrolife AB (OSTO:VITR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

0YAY:UK VTFN:Germany

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (OSTO:VITR) Headlines

No Headlines